News from REMEDY

The Nor-vaC study is one of the projects mentioned in the National report from the specialist health service 2022 - Research and innovation for the benefit of the patient.

Results from the ARCTIC REWIND study indicate that some arthritis patients can manage without medication.

The first annual report for the REMEDY center has now been published.

REMEDY research seminar for 2023 was conducted on 22-23 March at Sanner Hotell with a total of 120 registered participants. On 24 March, the Young researcher program had its own gathering with almost 50 participants.

This week it became formally clear that Daniel H. Solomon, professor at Harvard Medical School (Boston, USA) will be an official visiting professor at the research center REMEDY.

Diakonhjemmet Sykehus was awarded funds from Helse Sør-Öst for eight research projects, four of which are part of REMEDY. Three of the studies receiving funding are linked to remote monitoring/eHealth, while the fourth is a clinical study on hip fractures.

The Nor-vaC study concludes that repeated covid vaccination is safe and that it strengthens the antibody response in patients with inflammatory diseases of the joints and intestines.

Researcher Nina Østerås has presented the new research-based advice for osteoarthritis in VG. She emphasizes that even if the joints are characterized by osteoarthritis, movement and organized exercise will lead to better joint health.

As part of the European SQUEEZE collaboration, REMEDY receives 13 million to investigate therapeutic drug monitoring.